Archives
-
Epigenetic Upregulation of PDK1 Drives TKI Resistance in Can
2026-07-28
This study uncovers how epigenetic modifications involving KDM3A and METTL16 lead to elevated PDK1, mediating resistance to EGFR-TKIs and promoting tumor progression. The findings highlight the KDM3A/METTL16/PDK1 signaling axis as a potential target for overcoming drug resistance and improving programmed cell death research in oncology.
-
Synergistic 131I-MIBG and PARP Inhibitor Therapy in PPGL Mod
2026-07-28
Song et al. (2025) demonstrate that combining 131I-MIBG with PARP inhibition elicits a potent synthetic lethality effect in norepinephrine transporter-overexpressing pheochromocytoma and paraganglioma cell models. Their findings clarify the mechanistic role of NET in radionuclide uptake and highlight new possibilities for overcoming resistance in aggressive neuroendocrine tumors.
-
Gramine Induces Ferroptosis in TNBC via CUL3–MTDH Ubiquitina
2026-07-27
This study demonstrates that gramine (1-(1H-indol-3-yl)-N,N-dimethylmethanamine) selectively suppresses triple-negative breast cancer by inducing ferroptosis through a novel CUL3–MTDH ubiquitination mechanism. The findings highlight gramine’s mechanistic specificity and translational potential as a precision tool for ferroptosis research in oncology.
-
Melatonin Inhibits RIPK3-Mediated Necroptosis in Atrazine Ki
2026-07-27
This study reveals that melatonin protects against atrazine-induced kidney damage by directly inhibiting RIPK3-dependent necroptosis in renal tubular epithelial cells. The findings clarify the molecular mechanism underlying melatonin’s renal protection and highlight translational potential for mitigating chemical-induced nephrotoxicity.
-
2-APB: Precision Control of Calcium Signaling in Cell Fate S
2026-07-26
2-APB (2-aminoethoxydiphenyl borate) empowers researchers to dissect intricate calcium signaling pathways, modulate cell fate transitions, and optimize experimental assays with reproducible precision. This guide details advanced workflows, troubleshooting strategies, and translational insights—anchored in cutting-edge evidence and APExBIO’s reagent reliability.
-
Superoxide Dismutase (SOD) Activity Assay Kit: Protocol & QC
2026-07-25
The Superoxide Dismutase (SOD) Activity Assay Kit enables accurate quantification of SOD enzyme activity in biological fluids, supporting oxidative stress and antioxidative enzyme research. This kit is not intended for diagnostic or clinical use, and is best suited for controlled laboratory workflows requiring sensitive, colorimetric SOD measurement.
-
Thymoquinone Protects Against Doxorubicin Cardiotoxicity via
2026-07-24
This study demonstrates that thymoquinone, a phytochemical from Nigella sativa, significantly alleviates doxorubicin-induced cardiotoxicity in mice. The findings highlight activation of the Nrf2/HO-1 pathway and suppression of ferroptosis as core mechanisms, offering mechanistic insights for translational cardiac protection workflows.
-
ATP, Mitochondrial Regulation, and Translational Opportunity
2026-07-24
This thought-leadership article explores the evolving landscape of adenosine triphosphate (ATP) in cellular metabolism research, emphasizing its mechanistic role in mitochondrial regulation, particularly through post-translational modulation of the α-ketoglutarate dehydrogenase complex (OGDH) by TCAIM. By integrating highlights from Wang et al. (2025) and recent best practices, it offers strategic guidance and advanced protocol insights for translational researchers seeking to harness ATP’s full experimental and clinical potential.
-
Irinotecan (CPT-11): Protocol Innovations for Tumor Modeling
2026-07-23
Irinotecan (CPT-11) stands out as a topoisomerase I inhibitor optimized for advanced colorectal and gastric cancer research. This guide bridges cutting-edge assembloid modeling with robust experimental workflows, fine-tuned troubleshooting, and data-driven protocol enhancements—empowering researchers to unlock new insights into DNA damage, apoptosis, and therapeutic response.
-
Topological Stress Drives Persistent rDNA Damage and PML Rem
2026-07-23
This study uncovers how topological stress and RNA polymerase I inhibition induce persistent DNA lesions in ribosomal DNA, prompting the formation of PML-nucleolar compartments (PNAs). The findings clarify the molecular interplay between DNA damage, genome stability, and nucleolar structure, providing a framework for understanding senescence and tumorigenesis in response to nucleolar stress.
-
5-hme-dCTP: Enabling Single-Base Epigenetic DNA Modification
2026-07-22
5-hme-dCTP (5-Hydroxymethyl-2’-deoxycytidine-5’-Triphosphate) is a modified nucleotide analog used in high-resolution mapping of 5-hydroxymethylcytosine (5hmC), a key epigenetic mark. This article outlines its biochemical rationale, mechanism of action, and critical role in plant drought response research, with protocol guidance and benchmarked evidence.
-
Tetrandrine Alkaloid: Strategic Leverage in Translational Io
2026-07-22
This thought-leadership article explores how Tetrandrine, a high-purity alkaloid, empowers translational researchers to interrogate ion channel modulation, inflammation, and cancer biology with unprecedented mechanistic precision. We synthesize advanced protocol guidance, competitive positioning, and future outlook—bridging APExBIO’s product reliability with cross-domain innovation.
-
iMSC-Exosome Reprogramming of Macrophage-NP Crosstalk in IDD
2026-07-21
This study reveals that exosomes from human iPSC-derived MSCs interrupt the vicious cycle of inflammation and senescence between nucleus pulposus (NP) cells and macrophages in intervertebral disc degeneration (IDD). By delivering miR-100-5p, iMSC-exosomes reprogram macrophage metabolism and polarization, offering a mechanistically supported strategy for IDD mitigation.
-
ISRIB (trans-isomer): Advanced PERK Inhibitor for ER Stress
2026-07-21
ISRIB (trans-isomer) delivers precise inhibition of the integrated stress response, offering researchers a robust tool to dissect memory, apoptosis, and neuroinflammation pathways. Its validated potency and compatibility with in vitro and in vivo models make it indispensable for ER stress, cognitive enhancement, and neurodegenerative disease research.
-
Assessing pH-Mediated Interactions of Ribociclib Succinate i
2026-07-20
This study employs an Analytical Quality by Design approach to investigate whether acid-reducing agents impact the solubility and absorption of Ribociclib succinate, a selective CDK4/6 inhibitor used in HER2-positive metastatic breast cancer research. The findings indicate that clinically relevant pH shifts caused by acid-reducing agents do not significantly alter the drug's bioavailability, supporting flexible administration protocols.